Effect of piperacillin-tazobactam coated β-tricalcium phosphate for mastoid obliteration in otitis media

Jang, Chul Ho; Cho, Yong Bum; Yang, Hyung Chae; Kim, Jun Sung; Choi, Choong Hyeok; Jang, Sook-Jin; Park, Haekyun; Kim, GeunHyung

doi:10.1016/j.ijporl.2011.01.039

Cited by 8 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sorbone (META-BIOMED, Cheongju, Korea) was validated and received human study level II by a split-mouth study as a control of cockle-shell bone substitute in socket preservation34, and used as a control material for the effect of alendronate on periodontal intra-osseous defect35. SynCera (Oscotec, Seongnam, Korea) had animal and in vivo study for osteoconductivity3637. Cerasorb was approved by the FDA and commercially available to Cerasorb M which reduced porosity from 80% to 65%11.…”

Section: Resultsmentioning

confidence: 99%

Dental alloplastic bone substitutes currently available in Korea

Hong

Lee

et al. 2019

J Korean Assoc Oral Maxillofac Surg

View full text Add to dashboard Cite

As dental implant surgery and bone grafts were widely operated in Korean dentist, many bone substitutes are commercially available, currently. For commercially used in Korea, all bone substitutes are firstly evaluated by the Ministry of Health and Welfare (MOHW) for safety and efficacy of the product. After being priced, classified, and registration by the Health Insurance Review and Assessment Service (HIRA), the post-application management is obligatory for the manufacturer (or representative importer) to receive a certificate of Good Manufacturing Practice by Ministry of Food and Drug Safety. Currently, bone substitutes are broadly classified into C group (bone union and fracture fixation), T group (human tissue), L group (general and dental material) and non-insurance material group in MOHW notification No. 2018-248. Among them, bone substitutes classified as dental materials (L7) are divided as xenograft and alloplastic bone graft. The purpose of this paper is to analyze alloplastic bone substitutes of 37 products in MOHW notification No. 2018-248 and to evaluate the reference level based on the ISI Web of Knowledge, PubMed, EMBASE (1980–2019), Cochrane Database, and Google Scholar using the criteria of registered or trademarked product name.

show abstract

Section: Resultsmentioning

confidence: 99%